TERMIS BPC #TERMIS2022

Are you attending @TermisEU2022? 🎊 Here is a list for you to check: 1. Tickets ready?✈️ 2. Accomodation booked? 🏨 So you just need to vote for 2 panels happening with @SyisEu from the poll below👇

Well well ... basically 2⃣ months to go! #TERMISEU2022 🇵🇱 A stunning city 🏰🐉 and an amazing scientific community👩‍🔬 are waiting for you!

Good news! 💊 D e a d l i n e E x t e n d e d 🧫 to December 15th, 2021📆 Submit your Symposium Proposal, we look forward to receiving amazing proposals and get inspired by innovative thinking! #term #tissueengineering #regenerativemedicine

Starting in 10 minutes!

@antodg16 we would love to hear where you are now!

Throwback to when we brought our business idea to Sweden for @TERMISBPC 2016!

Need some advice writing your startup's business plan? We have a series of 5 pre-recorded webinars available on-demand to help you get your TERM assets through to market. Get first-hand advice from a series of industry leaders at the link. termisbpc.org/pap/

Only just over a month left to apply for the 2019 TERMIS-EU BPC! Get your business plans ready and submit now for a chance to present your startup at the @EuTermis 2019 European Congress. Apply here -> termisbpc.org

The 2019 TERMIS Business Plan Competition @TERMISBPC is open for applications!! If your tissue engineering/regen med startup needs mentorship & a cash boost, visit termisbpc.org and hit 'Apply' for a chance to pitch at TERMIS-EU 2019.

Take your startup success to the next step after @TERMISBPC - applications for @RebelBio Accelerator are open until 1st July - an opportunity win £200K on a three month incubator programme. #startup #lifescience

lnkd.in/eGWDw9Z lnkd.in/e5i_Qn9

Avro bio files for $86m IPO and set to become a major player in the ultra rare gene therapy space. fiercebiotech.com/biotech/lookin…

All star meeting @Stanford with a community of #celltherapy centres represented ft. David DiGiusto, Adrian Gee, Bruce Levine @StanfordMed @CAGTHouston @BLLPHD @PennMedicine @Baylor @ISCTglobal @TERMISBPC

Autolus, Arix and Syncona all emphasized that the IPO plan is in the preliminary stages and that the timing and terms are yet to be nailed down. The IPO could even fall through altogether: ow.ly/M1Qr30iMAlr

lnkd.in/gF2tw-R lnkd.in/gZnDdtj

A memorandum of understanding between @CGTCatapult and the Japanese Society for Regenerative Medicine was signed today. Pictured are Dr John Brown, CGTCatapult Chairman, and Yoshiki Sawa, President @JSRM_Official #Collaboration #RegenerativeMedicine - ow.ly/rLKR30iDXpa

#Autolus develops cancer therapies which will hopefully #transform lives with new therapies such as T-cell therapies #Innovateblog @innovateuk @UKRI_News ow.ly/OKPy30iucqE

Secondments can provide invaluable opportunity to broaden your skills, think laterally and change your perspective. @MeDe_Innovation @ISCTglobal @SyisEu #phdchat #ecrchat twitter.com/dr_d_miles/sta…

Case study: How @CGTCatapult worked with #cryochain technology experts @Asymptote_Ltd to create a new product and solve barriers in thawing #supplychain #coldchain - ow.ly/CMjO30imPrU

The cost of gene therapy is trending steadily downward, which is theoretically great for patients, but it still remains to be seen whether insurance will cover them. trib.al/csdXS5x

Fujifilm and Takeda Announce Collaboration to Develop Regenerative Medicine Therapies using Cardiomyocytes Derived from iPSC lnkd.in/ggqusPS